Useful resources |
Amantadine for dyskinesia in Parkinson's disease (Cochrane Review) ABSTRACT Background: Abnormal involuntary movements known as dyskinesias are amongst the most disabling side-effects of levodopa therapy. It is thought that amantadine, an NMDA-receptor antagonist, may reduce dyskinesias in patients with Parkinson's disease without worse . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |